JP2005527570A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005527570A5 JP2005527570A5 JP2003581716A JP2003581716A JP2005527570A5 JP 2005527570 A5 JP2005527570 A5 JP 2005527570A5 JP 2003581716 A JP2003581716 A JP 2003581716A JP 2003581716 A JP2003581716 A JP 2003581716A JP 2005527570 A5 JP2005527570 A5 JP 2005527570A5
- Authority
- JP
- Japan
- Prior art keywords
- antithrombin iii
- composition
- composition according
- lung injury
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 14
- 102000004411 Antithrombin III Human genes 0.000 claims 9
- 108090000935 Antithrombin III Proteins 0.000 claims 9
- 229960005348 antithrombin iii Drugs 0.000 claims 9
- 208000004852 Lung Injury Diseases 0.000 claims 4
- 206010069363 Traumatic lung injury Diseases 0.000 claims 4
- 231100000515 lung injury Toxicity 0.000 claims 4
- 206010069351 acute lung injury Diseases 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 1
- 239000010425 asbestos Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 239000006199 nebulizer Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 229910052895 riebeckite Inorganic materials 0.000 claims 1
- 239000000779 smoke Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36899702P | 2002-04-01 | 2002-04-01 | |
| PCT/US2003/009053 WO2003084476A2 (en) | 2002-04-01 | 2003-03-25 | Treatment of lung disorder |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011176604A Division JP2011225625A (ja) | 2002-04-01 | 2011-08-12 | 肺障害の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005527570A JP2005527570A (ja) | 2005-09-15 |
| JP2005527570A5 true JP2005527570A5 (enExample) | 2006-05-25 |
Family
ID=29420316
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003581716A Pending JP2005527570A (ja) | 2002-04-01 | 2003-03-25 | 肺障害の治療 |
| JP2011176604A Withdrawn JP2011225625A (ja) | 2002-04-01 | 2011-08-12 | 肺障害の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011176604A Withdrawn JP2011225625A (ja) | 2002-04-01 | 2011-08-12 | 肺障害の治療 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090221475A9 (enExample) |
| EP (1) | EP1494696A4 (enExample) |
| JP (2) | JP2005527570A (enExample) |
| KR (2) | KR20040105838A (enExample) |
| CN (1) | CN100384469C (enExample) |
| AU (3) | AU2003233428B2 (enExample) |
| CA (1) | CA2480790A1 (enExample) |
| IL (2) | IL164078A0 (enExample) |
| NZ (1) | NZ535487A (enExample) |
| WO (1) | WO2003084476A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050169908A1 (en) * | 2004-01-23 | 2005-08-04 | Kazunori Murakami | Use of aerosolized antithrombin to treat acute lung injury |
| US20050192226A1 (en) * | 2004-02-20 | 2005-09-01 | Perenlei Enkhbaatar | Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants |
| US20050245444A1 (en) * | 2004-04-30 | 2005-11-03 | Yann Echelard | Method of using recombinant human antithrombin for neurocognitive disorders |
| US20060121004A1 (en) * | 2004-12-07 | 2006-06-08 | Yann Echelard | Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin |
| WO2012051339A2 (en) * | 2010-10-12 | 2012-04-19 | Vetgel Technologies | Methods and compositions for treating respiratory conditions using platelet enriched plasma |
| WO2012090067A1 (en) | 2010-12-30 | 2012-07-05 | Lfb Biotechnologies | Glycols as pathogen inactivating agents |
| US10174110B2 (en) | 2013-02-13 | 2019-01-08 | Laboratoire Français Du Fractionnement Et Des Biotechnologies | Highly galactosylated anti-TNF-α antibodies and uses thereof |
| WO2014140927A2 (en) | 2013-02-13 | 2014-09-18 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Proteins with modified glycosylation and methods of production thereof |
| KR20160029840A (ko) | 2013-07-05 | 2016-03-15 | 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 | 친화성 크로마토그래피 매트릭스 |
| JP6779866B2 (ja) | 2014-06-13 | 2020-11-04 | チルドレンズ メディカル センター コーポレイション | ミトコンドリアを単離するための製品および方法 |
| FR3038517B1 (fr) | 2015-07-06 | 2020-02-28 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Utilisation de fragments fc modifies en immunotherapie |
| WO2017124037A1 (en) | 2016-01-15 | 2017-07-20 | The Children's Medical Center Corporation | Therapeutic use of mitochondria and combined mitochondrial agents |
| WO2020214644A1 (en) * | 2019-04-15 | 2020-10-22 | Children's Medical Center Corporation | Aerosolized compositions comprising mitochondria and methods of use thereof |
| JP2024509735A (ja) * | 2021-02-17 | 2024-03-05 | ユニヴァーシティ オヴ ロチェスター | 敗血症の予後を処置、診断及び予測する方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08782B2 (ja) * | 1986-11-22 | 1996-01-10 | 株式会社ミドリ十字 | 抗炎症剤 |
| DE4117078A1 (de) * | 1991-05-25 | 1992-11-26 | Boehringer Ingelheim Kg | Verfahren zur herstellung therapeutisch anwendbarer aerosole |
| JPH06256213A (ja) * | 1993-03-03 | 1994-09-13 | Green Cross Corp:The | ヒト由来アンチトロンビン−ｉｉｉの医薬用途 |
| US6127347A (en) * | 1994-01-12 | 2000-10-03 | Univ Michigan | Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
| US6355626B1 (en) * | 1994-05-13 | 2002-03-12 | The Trustees Of The University Of Pennsylvania | Antithrombin agents in treatment of asthma |
| US5843705A (en) * | 1995-02-21 | 1998-12-01 | Genzyme Transgenic Corporation | Transgenically produced antithrombin III |
| US6562781B1 (en) * | 1995-11-30 | 2003-05-13 | Hamilton Civic Hospitals Research Development Inc. | Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
| US7045585B2 (en) * | 1995-11-30 | 2006-05-16 | Hamilton Civic Hospital Research Development Inc. | Methods of coating a device using anti-thrombin heparin |
| JPH09176040A (ja) * | 1995-12-27 | 1997-07-08 | Green Cross Corp:The | ヘパリンコファクターｉｉの医薬用途 |
| US6063593A (en) * | 1996-11-12 | 2000-05-16 | University Of Southern California University Park Campus | TGFβ1 responsive bone marrow derived cells to express a recombinant protein |
| US6124257A (en) * | 1997-08-28 | 2000-09-26 | Lezdey; John | Method of treatment |
| IL142639A0 (en) * | 1998-10-20 | 2002-03-10 | Childrens Hosp Medical Center | Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| US6838428B2 (en) * | 1998-10-20 | 2005-01-04 | Children's Hospital Medical Center | Surfactant protein D for the prevention and diagnosis of pulmonary emphysema |
| DE10045047A1 (de) * | 2000-09-12 | 2002-03-21 | Beate Kehrel | Arzneimittel enthaltend aktiviertes Antithrombin III |
| AU2002224408B2 (en) * | 2000-10-18 | 2007-08-23 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
| DE10132307A1 (de) * | 2001-07-06 | 2003-01-30 | Aventis Behring Gmbh | Arzneizubereitung zur Inhalation von Antithrombin bei entzündlichen Lungenerkrankungen und ARDS |
| US20050169908A1 (en) * | 2004-01-23 | 2005-08-04 | Kazunori Murakami | Use of aerosolized antithrombin to treat acute lung injury |
| US20050192226A1 (en) * | 2004-02-20 | 2005-09-01 | Perenlei Enkhbaatar | Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants |
-
2003
- 2003-03-25 AU AU2003233428A patent/AU2003233428B2/en not_active Revoked
- 2003-03-25 EP EP03728277A patent/EP1494696A4/en not_active Withdrawn
- 2003-03-25 IL IL16407803A patent/IL164078A0/xx active IP Right Grant
- 2003-03-25 CN CNB03807463XA patent/CN100384469C/zh not_active Expired - Fee Related
- 2003-03-25 WO PCT/US2003/009053 patent/WO2003084476A2/en not_active Ceased
- 2003-03-25 KR KR10-2004-7015636A patent/KR20040105838A/ko not_active Ceased
- 2003-03-25 KR KR1020107022448A patent/KR20100117148A/ko not_active Ceased
- 2003-03-25 US US10/396,855 patent/US20090221475A9/en not_active Abandoned
- 2003-03-25 CA CA002480790A patent/CA2480790A1/en not_active Abandoned
- 2003-03-25 JP JP2003581716A patent/JP2005527570A/ja active Pending
- 2003-03-25 NZ NZ535487A patent/NZ535487A/en not_active IP Right Cessation
-
2004
- 2004-09-14 IL IL164078A patent/IL164078A/en not_active IP Right Cessation
-
2008
- 2008-10-31 AU AU2008243077A patent/AU2008243077A1/en not_active Withdrawn
-
2011
- 2011-08-12 JP JP2011176604A patent/JP2011225625A/ja not_active Withdrawn
- 2011-10-10 AU AU2011236070A patent/AU2011236070A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005527570A5 (enExample) | ||
| Wilkes | Heat and moisture exchangers and breathing system filters: their use in anaesthesia and intensive care. Part 1–history, principles and efficiency | |
| JP2002529396A5 (enExample) | ||
| DK0740550T3 (da) | Anvendelse af mometasonfurat til behandling af sygdomme i luftveje og lunger | |
| EA200200551A1 (ru) | Новые содержащие тиотропий порошки для ингаляции | |
| NO20024708L (no) | Behandling av respiratoriske sykdommer | |
| WO2005087253A3 (en) | Interferon-beta for anti-virus therapy for respiratory diseases | |
| JP2007518801A5 (enExample) | ||
| CY1108420T1 (el) | Προτοτυπο τιοτροπιουχο κονιωδες σκευασμα για εισπνοη | |
| JP2007533657A5 (enExample) | ||
| NO20073909L (no) | Forstover-formulering | |
| JP2002345966A (ja) | 吸入器への呼気逆流防止装置 | |
| DE60314422D1 (de) | Inhalator | |
| ATE276761T1 (de) | Vorbeugung von typ-1 diabetes und anderen nicht- polio enteroviren | |
| JP2003528925A5 (enExample) | ||
| EA200701077A1 (ru) | Применение конъюгатов липидов при лечении заболеваний | |
| Plaut | One Minute Asthma: What you need to know | |
| JP7516308B2 (ja) | 呼気殺菌装置 | |
| Öztürk et al. | Role of SARS-CoV-2 in asthma exacerbations | |
| JP3232632U (ja) | 呼気ウイルス不活化システム | |
| RU2002114535A (ru) | Способ лечения бронхиальной астмы у детей в приступном периоде | |
| Misra | A short review on important drugs under clinical trial against Covid-19 | |
| JP2002306597A (ja) | 吸入器への呼気逆流防止装置 | |
| Rajesh et al. | T‑Piece for COVID‑19 Patients: Innovation in a Time of Crisis | |
| JP2025505045A (ja) | 空気を処理するためのフィルタシステム及びその使用方法 |